Skip to main content

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ: BCRX )

7.570 +0.180 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
September 25, 2016
Form CT ORDER
Source: SEC/Edgar
September 13, 2016
Form 8-K
Source: SEC/Edgar
September 06, 2016
Form SC 13G
Source: SEC/Edgar
August 25, 2016
Form SC 13G
Source: SEC/Edgar
August 21, 2016
Form SC 13G
Source: SEC/Edgar
August 16, 2016
Form SC 13D/A
Source: SEC/Edgar
August 15, 2016
Form SC 13G
Source: SEC/Edgar
August 11, 2016
Form 8-K
Source: SEC/Edgar
August 10, 2016
Form 8-K
Source: SEC/Edgar
August 03, 2016
Form CT ORDER
Source: SEC/Edgar
July 25, 2016
Form 8-K
Source: SEC/Edgar
July 04, 2016
Form CT ORDER
Source: SEC/Edgar
June 08, 2016
Form 8-K
Source: SEC/Edgar
May 24, 2016
Form S-8
Source: SEC/Edgar
May 22, 2016
Form 8-K
Source: SEC/Edgar
May 04, 2016
Form EFFECT
Source: SEC/Edgar
April 17, 2016
Form DEF 14A
Source: SEC/Edgar
April 10, 2016
Form SC 13G/A
Source: SEC/Edgar
April 10, 2016
Form DEFA14A
Source: SEC/Edgar
April 10, 2016
Form SC 13G
Source: SEC/Edgar
March 27, 2016
Form SC 13G
Source: SEC/Edgar
March 13, 2016
Form SC 13G/A
Source: SEC/Edgar
March 09, 2016
Form 8-K
Source: SEC/Edgar
March 07, 2016
Form 8-K
Source: SEC/Edgar
March 06, 2016
Form POS AM
Source: SEC/Edgar
February 25, 2016
Form 8-K
Source: SEC/Edgar
February 22, 2016
Form SC 13G/A
Source: SEC/Edgar
February 15, 2016
Form SC 13G/A
Source: SEC/Edgar
February 11, 2016
Form SC 13G/A
Source: SEC/Edgar
February 10, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.